AAAAAA

   
Results: 1-15 |
Results: 15
Effect of parathyroid hormone (1-34) on fractures and bone mineral densityin postmenopausal women with osteoporosis.
Authors: Neer, RM Arnaud, CD Zanchetta, JR Prince, R Gaich, GA Reginster, JY Hodsman, AB Eriksen, EF Ish-Shalom, S Genant, HK Wang, OH Mitlak, BH
Citation: Rm. Neer et al., Effect of parathyroid hormone (1-34) on fractures and bone mineral densityin postmenopausal women with osteoporosis., N ENG J MED, 344(19), 2001, pp. 1434-1441
Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis
Authors: Hodsman, AB Kisiel, M Adachi, JD Fraher, LJ Watson, PH
Citation: Ab. Hodsman et al., Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis, BONE, 27(2), 2000, pp. 311-318
Nuclear localization of the type 1 parathyroid hormone parathyroid hormone-related peptide receptor in MC3T3-E1 cells: Association with serum-inducedcell proliferation
Authors: Watson, PH Fraher, LJ Natale, BV Kisiel, M Hendy, GN Hodsman, AB
Citation: Ph. Watson et al., Nuclear localization of the type 1 parathyroid hormone parathyroid hormone-related peptide receptor in MC3T3-E1 cells: Association with serum-inducedcell proliferation, BONE, 26(3), 2000, pp. 221-225
Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis
Authors: Crilly, RG Sebaldt, RJ Hodsman, AB Adachi, JD Brown, JP Goldsmith, CH Hanley, DA Olszynski, WO Ste-Marie, LG Stephenson, GF
Citation: Rg. Crilly et al., Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis, OSTEOPOR IN, 11(7), 2000, pp. 607-614
Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues
Authors: Watson, PH Fraher, LJ Hendy, GN Chung, UI Kisiel, M Natale, BV Hodsman, AB
Citation: Ph. Watson et al., Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues, J BONE MIN, 15(6), 2000, pp. 1033-1044
Rapid small-animal dual-energy X-ray absorptiometry using digital radiography
Authors: Holdsworth, DW Thornton, MM Drost, D Watson, PH Fraher, LJ Hodsman, AB
Citation: Dw. Holdsworth et al., Rapid small-animal dual-energy X-ray absorptiometry using digital radiography, J BONE MIN, 15(12), 2000, pp. 2451-2457
The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu(27)]cyclo(Glu(22)-Lys(26))hPTH-(1-31)NH2, and hPTH-(1-30)NH2
Authors: Whitfield, JF Morley, P Fraher, L Hodsman, AB Holdsworth, DW Watson, PH Willick, GE Barbier, JR Gulam, M Isaacs, RJ MacLean, S Ross, V
Citation: Jf. Whitfield et al., The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu(27)]cyclo(Glu(22)-Lys(26))hPTH-(1-31)NH2, and hPTH-(1-30)NH2, CALCIF TIS, 66(4), 2000, pp. 307-312
Management of corticosteroid-induced osteoporosis
Authors: Adachi, JD Olszynski, WP Hanley, DA Hodsman, AB Kendler, DL Siminoski, KG Brown, J Cowden, EA Goltzman, D Ioannidis, G Josse, RG Ste-Marie, LG Tenenhouse, AM Davison, KS Blocka, KLN Pollock, AP Sibley, J
Citation: Jd. Adachi et al., Management of corticosteroid-induced osteoporosis, SEM ARTH RH, 29(4), 2000, pp. 228-251
Bone mineral measurement of phalanges: Comparison of radiographic absorptiometry and area dual X-ray absorptiometry
Authors: Gulam, M Thornton, MM Hodsman, AB Holdsworth, DW
Citation: M. Gulam et al., Bone mineral measurement of phalanges: Comparison of radiographic absorptiometry and area dual X-ray absorptiometry, RADIOLOGY, 216(2), 2000, pp. 586-591
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate
Authors: Rittmaster, RS Bolognese, M Ettinger, MP Hanley, DA Hodsman, AB Kendler, DL Rosen, CJ
Citation: Rs. Rittmaster et al., Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate, J CLIN END, 85(6), 2000, pp. 2129-2134
Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat
Authors: Hodsman, AB Watson, PH Drost, D Holdsworth, D Thornton, M Hock, J Bryant, H Fraher, LJ
Citation: Ab. Hodsman et al., Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat, BONE, 24(5), 1999, pp. 451-455
Enhanced osteoblast development after continuous infusion of hPTH(1-84) inthe rat
Authors: Watson, PH Fraher, LJ Kisiel, M DeSousa, D Hendy, G Hodsman, AB
Citation: Ph. Watson et al., Enhanced osteoblast development after continuous infusion of hPTH(1-84) inthe rat, BONE, 24(2), 1999, pp. 89-94
The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats
Authors: Hodsman, AB Drost, D Fraher, LJ Holdsworth, D Thornton, M Hock, J Bryant, H Watson, PH
Citation: Ab. Hodsman et al., The addition of a raloxifene analog (LY117018) allows for reduced PTH(1-34) dosing during reversal of osteopenia in ovariectomized rats, J BONE MIN, 14(5), 1999, pp. 675-679
Serum osteocalcin and procollagen as markers for the risk of osteoporotic fracture in corticosteroid-treated asthmatic adults
Authors: Toogood, JH Hodsman, AB Fraher, LJ Markov, AE Baskerville, JC
Citation: Jh. Toogood et al., Serum osteocalcin and procollagen as markers for the risk of osteoporotic fracture in corticosteroid-treated asthmatic adults, J ALLERG CL, 104(4), 1999, pp. 769-774
Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans
Authors: Fraher, LJ Avram, R Watson, PH Hendy, GN Henderson, JE Chong, KL Goltzman, D Morley, P Willick, GE Whitfield, JF Hodsman, AB
Citation: Lj. Fraher et al., Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans, J CLIN END, 84(8), 1999, pp. 2739-2743
Risultati: 1-15 |